Navigation Links
Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer

pain’ satellite symposium can be found.

About Nycomed

Nycomed is an international pharmaceutical group that provides products for hospitals, specialists and general practitioners, as well as over-the-counter medicines in selected markets.

The company is active within a range of therapeutic areas, including cardiology, gastroenterology, osteoporosis, respiratory, pain and tissue management. New products are sourced both from own research and from external partners. Operating throughout Europe and in fast-growing markets such as Latin America, Russia/CIS and the Asia-Pacific region Nycomed has a presence in about 50 markets worldwide.

Privately owned, the combined group had non-audited estimated annual sales of approximately €3.4 billion and an EBITDA of €933.4 million (2006 results). In connection with the acquisition of the ALTANA Pharma AG, effective 1 January 2007, Nycomed is relocating its group headquarters from Roskilde (Denmark) to Zurich (Switzerland) in June 2007.

For more information visit www.nycomed.com

For further information

Dr Susan Craib, Wells Healthcare
Phone: +44 [0]1892 511600
Mobile: +44 [0]7703 544 957

Germany:
Susanne Hof, Nycomed, Head of External Communications
Phone: +49 7531 84 30 59
Mobile: +49 151 55 00 26 65

References

1. Popper L, Christrup L. Breakthrough pain: a randomised trial comparing nasal and intravenous fentanyl in patients with p
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
3. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
4. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
5. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
6. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
7. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
8. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
9. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
10. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
11. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
Post Your Comments:
(Date:8/29/2014)... and MENLO PARK, Calif. , Aug. ... (OTCQB: DMPI) ("DelMar" "the Company") today announced the ... The Company recently changed its fiscal year end to ... list its common stock on a national securities exchange ... statements as filed with the United States Securities Exchange ...
(Date:8/29/2014)... -- Research and Markets  has announced the addition ... Market 2014-2018" report to their offering. ... that connect, support, or surround bones. There are several ... cartilage, fascia, and other fibrous tissues. Repetitive use, accidents, ... result in wear and tear in these tissues. Orthopedic ...
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire/ –  ... PHG AEX: PHIA) today announced ... Society of Cardiology (ESC) Congress 2014 ... range of its cardiology solutions serving clinicians and ... prevention and diagnosis, to treatment, ...
Breaking Medicine Technology:DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 5Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 3Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 2Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 3Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 4Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 5
(Date:8/30/2014)... "My niece developed a nighttime fever, and I ... fever might get worse," said an inventor from Montgomery, ... how she was doing, I developed this monitoring system." ... a child's temperature. The unit instantly alerts parents if ... medical care can be given, which is designed to ...
(Date:8/30/2014)... August 2014: Transvenous lead extraction (TLE) is clinically successful ... from the European Lead Extraction ConTRolled (ELECTRa) registry presented ... by Dr Maria Grazia Bongiorni, chair of the registry,s ... cardiac implantable electronic devices (CIED) implant procedures has grown ... of complications has increased and leads are often the ...
(Date:8/30/2014)... The new review published by Daily Gossip ... Karen Brimeyer, who wanted to make her guide accessible to ... is now easy to find in the form of an ... the author of the new method shares all her tips ... writes in its review that the leaky gut syndrome can ...
(Date:8/30/2014)... Flagstaff, AZ (PRWEB) August 30, 2014 Jake ... High School while in the Back2Basics Outdoor Adventures ... want to finish high school so I can actually start ... need English and math, and I'm done.” , He has ... the initial Back2Basics program. Most clients choose to continue on ...
(Date:8/30/2014)... As 500 Zoloft lawsuits pending ligation contend the SSRI ... Wright & Schulte LLC recently learned of a remand issued ... remand in the Zoloft lawsuits was granted to 25 ... in one SSRI lawsuit filed jointly under MDL ... lawsuit sent back to the Missouri state court in which ...
Breaking Medicine News(10 mins):Health News:Transvenous lead extraction clinically successful in 98 percent of cases 2Health News:Transvenous lead extraction clinically successful in 98 percent of cases 3Health News:Leaky Gut Cure Review Reveals Unique Method to Stop Chronic Symptoms 2Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 2Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 3Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 4Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 5
... Designed to Reduce the Risk of a Subsequent Stroke, ... today,announced the launch of The TIA (Transient Ischemic Attack) ... the first of its kind in,Central Texas -- in ... stroke after TIA., A TIA is a "warning ...
... NET SatisFAXtion recognized for highly reliable and secure VoIP fax solutions ... ... (Vocus) October 27, 2008 -- FaxBack® , the leading provider ... INTERNET TELEPHONY® Magazine - the VoIP authority since 1998 - has ...
... - Special Needs Plan focuses on added benefits ... for Medicare beneficiaries with chronic health conditions -, ... the upcoming,Medicare annual enrollment period which begins November ... its 2009 Special Needs Plan,(SNP) offerings for chronically ...
... to $4.7 million in the ... revenue of $4.3 million in the first quarter of fiscal 2009, a 26% ... year-over-year increase, - Strong sales to pharmaceutical manufacturers and retail market customers ... drove growth in the first quarter - ...
... Dietitian Kris Clark, Ph.D., offers easy tips ... and fun - Halloween!, WASHINGTON, Oct. 27 If ... aged five to thirteen years, are,poised to don costumes to ... on sweet treats, registered dietitian Kris Clark,Ph.D., of Pennsylvania State ...
... Business Impact for the development of an automated process to dramatically ... , ... Irvine, CA (Vocus) October 27, 2008 -- When ... , , ,LifeMasters Supported SelfCare, Inc. is strengthening its health improvement ...
Cached Medicine News:Health News:St. David's HealthCare Launches The TIA Center for Stroke Prevention at St. David's Medical Center 2Health News:St. David's HealthCare Launches The TIA Center for Stroke Prevention at St. David's Medical Center 3Health News:FaxBack Wins the 2008 Internet Telephony Excellence Award 2Health News:FaxBack Wins the 2008 Internet Telephony Excellence Award 3Health News:Care Improvement Plus Launches 2009 Benefits in Georgia 2Health News:Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009 2Health News:Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009 3Health News:Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009 4Health News:Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009 5Health News:Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009 6Health News:Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009 7Health News:Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009 8Health News:No Trick to Halloween Sweet Treats 2Health News:No Trick to Halloween Sweet Treats 3Health News:LifeMasters Receives 2008 Vision Award for Business Impact 2Health News:LifeMasters Receives 2008 Vision Award for Business Impact 3
... microplate washers available to handle ... cell-based assays. Embla 384 Cell ... have been optimized to avoid ... robotic compatible and have been ...
... The Labcyte miniGene LW is a new plate ... to 96 and 384 channel microplates with flat, ... equipped with 8 or 16 channel nozzle heads. ... a breeze. An optional plate stacker is available ...
Space-saving counter top model,User initiated manual defrost,Standard features (see above),Internal freezing compartment,Removable half-shelf in refrigerator,Two shelves in door,UL 471 Commercial Ref...
... to 8000 L/day of Type III Laboratory-grade ... to produce up to 8000 L/day of ... feedwater., One Complete Purification and Control Unit, ... centralized system, providing total control of all ...
Medicine Products: